Sun Pharma Advanced Research Company informs about outcome of rights issue committee meeting

27 Apr 2016 Evaluate

Sun Pharma Advanced Research Company has informed that the Right Issue Committee of Director, authorized by board of directors, at its meeting on April 27, 2016 from 10:00 am to 10:30 am, has approved the allotment of 10,204,081 fully paid-up equity shares of face value of Re 1 each at a price of Rs. 245 per equity share (including a share premium of Rs 244 per equity share) issued on a Right basis, to all eligible applicants who have subscribed to the said issue and whose applications were valid.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

133.75 -0.30 (-0.22%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 654.25
Indegene 522.50
CMS Info Systems 343.20
Sagility 52.23
Smartworks Coworking 472.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×